Details for Patent: 8,987,463

Which drugs does patent 8,987,463 protect, and when does it expire?

Patent 8,987,463 protects BEVYXXA and is included in one NDA.

This patent has twelve patent family members in nine countries.

Summary for Patent: 8,987,463

Title:	Methods of synthesizing factor Xa inhibitors
Abstract:	Described herein are novel methods of preparing a compound of Formula II or a pharmaceutically acceptable salt thereof. In some embodiments, the method is for preparing betrixaban or a pharmaceutically acceptable salt thereof. Also described are compositions comprising substantially pure betrixaban free base or salt thereof. ##STR00001##
Inventor(s):	Pandey; Anjali (Fremont, CA), Leitao; Emilia P. T. (Lisbon, PT), Rato; Jose (Lisbon, PT), Song; Zhiguo Jake (Edison, NJ)
Assignee:	Millennium Pharmaceuticals, Inc. (Cambridge, MA) Portola Pharmaceuticals, Inc. (South San Francisco, CA)
Application Number:	13/757,483
Patent Claim Types: see list of patent claims	Composition;

Drugs Protected by US Patent 8,987,463

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Portola Pharms Inc	BEVYXXA	betrixaban	CAPSULE;ORAL	208383-001	Jun 23, 2017		DISCN	Yes	No			Y
Portola Pharms Inc	BEVYXXA	betrixaban	CAPSULE;ORAL	208383-002	Jun 23, 2017		DISCN	Yes	No			Y

International Family Members for US Patent 8,987,463

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Argentina	079491
Canada	2784904
China	102762538
China	104774176
European Patent Office	2513058
Spain	2610145